Articles

Are investors really suffering because companies report earnings every 3 months?

Rather than short-term pressure, companies typically get a long leash from hopeful shareholders.

No recession ahead — and more stock-friendly takeaways from recent earnings reports

Consumers will keep spending, AI and tech aren’t in a bubble, and the stock market has room to run.

The Fed’s interest-rate cuts are fueling a stock market ‘melt-up’ — and ruin for some investors

A buildup in leverage would make the financial system more vulnerable and susceptible to shocks.

Inside the zero-revenue nuclear stock whose 1,500% rally is shaking up the AI trade

Now worth $20 billion, Oklo has become the largest pre-revenue company listed in the U.S., as investors search for the next big AI trade.

I’m 66. My mortgage is $250K and the rate is 3.4%. Would it be foolish to pay it off from my $770K investments?

“I don’t plan on taking Social Security until 70 and I will have one other small pension.”

Why Big Tech’s tiny production costs make it a long term winner, says this fund manager

AOT Growth and Innovation ETF portfolio manager, John Tinsman says there’s one clear reason to invest in big tech companies: low marginal cost.

My mother left me $600K in Apple shares. They are 50% of my portfolio. Am I crazy if I don’t diversify?

“I worry that a downturn in the tech sector, or something Apple-specific, could wipe out half my portfolio.”

Quantum-computing stocks have been red hot. HSBC has just claimed a major trading breakthrough using the technology.

The banking giant says it has shown the technology improves its algorithmic bond dealing.

Trump wanted Jimmy Kimmel cancelled. He gave him his highest ratings in 10 years instead.

Jimmy Kimmel’s free-speech fight with the Trump administration has turned out to be a ratings bonanza.

Will Apple deliver Intel its next lifeline? Here’s why analysts think a deal would make sense.

The chip maker has reportedly asked Apple for an investment as it attempts to save its faltering business with a slew of multi-billion-dollar deals

Why it’s time to sell Bloom Energy’s stock after its AI-fueled rally

Jefferies analyst downgrades Bloom Energy’s stock to underperform, saying the rally since the company’s power-generation deal with Oracle in July was a sign of ‘over-exuberance’ by investors.

Here’s why biotech UniQure’s stock just tripled, and brought ClearPoint shares up with it

A ClearPoint Neuro’s medical device plays an important role in UniQure’s effort to battle Huntington’s disease.
1 47 48 49 50 51 2,370